You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 24, 2024

DARZALEX Drug Profile


✉ Email this page to a colleague

« Back to Dashboard


Summary for Tradename: DARZALEX
High Confidence Patents:0
Applicants:1
BLAs:2
Recent Clinical Trials: See clinical trials for DARZALEX
Recent Clinical Trials for DARZALEX

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Nantes University HospitalPhase 1
Shanghai Henlius BiotechPhase 1
Institute of Hematology & Blood Diseases HospitalEarly Phase 1

See all DARZALEX clinical trials

Pharmacology for DARZALEX
Mechanism of ActionCD38-directed Antibody Interactions
Established Pharmacologic ClassCD38-directed Cytolytic Antibody
Chemical StructureAntibodies, Monoclonal
Note on Biologic Patents

Matching patents to biologic drugs is far more complicated than for small-molecule drugs.

DrugPatentWatch employs three methods to identify biologic patents:

  1. Brand-side disclosures in response to biosimilar applications
  2. These patents were identified from disclosures by the brand-side company, in response to a potential biosimilar seeking to launch. They have a high certainty of blocking biosimilar entry. The expiration dates listed are not estimates — they're expiration dates as indicated by the brand-side company.

  3. General brand-side disclosures
  4. These patents were identified from searching drug labels and other general disclosures from the brand-side company. This list may exclude some of the patents which block biosimilar launch, and some of these patents listed may not actually block biosimilar launch. The expiration dates listed for these patents are estimates, based on the grant date of the patent.

  5. Patents from broad patent text search
  6. For completeness, these patents were identified by searching the patent literature for mentions of the branded or ingredient name of the drug. Some of these patents protect the original drug, whereas others may protect follow-on inventions or even inventions casually mentioning the drug. The expiration dates listed for these patents are estimates, based on the grant date of the patent.

1) High Certainty: US Patents for DARZALEX Derived from Brand-Side Litigation

No patents found based on brand-side litigation

2) High Certainty: US Patents for DARZALEX Derived from Company Disclosures

These patents were obtained from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Patent No. Estimated Patent Expiration Source
Janssen Biotech, Inc. DARZALEX daratumumab Injection 761036 ⤷  Sign Up Company disclosures
Janssen Biotech, Inc. DARZALEX daratumumab Injection 761036 ⤷  Sign Up 2027-09-26 Company disclosures
Janssen Biotech, Inc. DARZALEX daratumumab Injection 761036 ⤷  Sign Up 2030-09-21 Company disclosures
Janssen Biotech, Inc. DARZALEX FASPRO daratumumab and hyaluronidase-fihj Injection 761145 ⤷  Sign Up 2040-10-06 Company disclosures
Janssen Biotech, Inc. DARZALEX FASPRO daratumumab and hyaluronidase-fihj Injection 761145 ⤷  Sign Up Company disclosures
Janssen Biotech, Inc. DARZALEX FASPRO daratumumab and hyaluronidase-fihj Injection 761145 ⤷  Sign Up Company disclosures
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Patent No. >Estimated Patent Expiration >Source

3) Low Certainty: US Patents for DARZALEX Derived from Patent Text Search

These patents were obtained by searching patent claims

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.